Mesothelioma natural history: Difference between revisions
| Line 24: | Line 24: | ||
! style="background: #4479BA; width: 400px;" | {{fontcolor|#FFF|Approximate median survival}} | ! style="background: #4479BA; width: 400px;" | {{fontcolor|#FFF|Approximate median survival}} | ||
|- | |- | ||
| style="padding: 5px 5px; background: #DCDCDC;" align=center|Pleural | | style="padding: 5px 5px; background: #DCDCDC;" align=center|[[Pleural]] | ||
| style="padding: 5px 5px; background: #DCDCDC;" align=center|4-18 months | | style="padding: 5px 5px; background: #DCDCDC;" align=center|4-18 months | ||
|- | |- | ||
| style="padding: 5px 5px; background: #DCDCDC;" align=center|Peritoneal | | style="padding: 5px 5px; background: #DCDCDC;" align=center|[[Peritoneal]] | ||
| style="padding: 5px 5px; background: #DCDCDC;" align=center|5-12 months | | style="padding: 5px 5px; background: #DCDCDC;" align=center|5-12 months | ||
|- | |- | ||
| style="padding: 5px 5px; background: #DCDCDC;" align=center|Pericardial | | style="padding: 5px 5px; background: #DCDCDC;" align=center|[[Pericardial]] | ||
| style="padding: 5px 5px; background: #DCDCDC;" align=center|6 months | | style="padding: 5px 5px; background: #DCDCDC;" align=center|6 months | ||
|- | |- | ||
| style="padding: 5px 5px; background: #DCDCDC;" align=center|Tunica vaginalis testis | | style="padding: 5px 5px; background: #DCDCDC;" align=center|[[Tunica vaginalis testis]] | ||
| style="padding: 5px 5px; background: #DCDCDC;" align=center|23 months | | style="padding: 5px 5px; background: #DCDCDC;" align=center|23 months | ||
|} | |} | ||
Revision as of 21:59, 5 February 2016
|
Mesothelioma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Mesothelioma natural history On the Web |
|
American Roentgen Ray Society Images of Mesothelioma natural history |
|
Risk calculators and risk factors for Mesothelioma natural history |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Parminder Dhingra, M.D. [2], Sujit Routray, M.D. [3]
Overview
Natural History
Complications
- Blood clots in the veins, which may cause thrombophlebitis
- Disseminated intravascular coagulation, a disorder causing severe bleeding in many body organs
- Pulmonary emboli, or blood clots in the arteries of the lungs
- Severe ascites
Prognosis
A mesothelioma is a highly aggressive tumor that is generally deadly. Current treatment of malignant mesothelioma is designed to make the person with cancer comfortable. Although long-term survival cannot usually be expected, the case of famed paleontologist Stephen Jay Gould is a noted exception.
Mesothelioma is not contagious and cannot be passed from one person to another. The exposure to the asbestos that caused the cancer occurred many years to several decades before the disease appeared. People who live with asbestos workers have a higher risk of getting this cancer.
Although mesothelioma is very unpleasant it's still important for person after treatment is over to keep up all follow-up appointments and that's vital because further testing is always needed to check whether cancer is coming back or to examine possible side effects that could be rather unpleasant and what's even worse permanent.
| Location of mesothelioma | Approximate median survival |
|---|---|
| Pleural | 4-18 months |
| Peritoneal | 5-12 months |
| Pericardial | 6 months |
| Tunica vaginalis testis | 23 months |